January 2, 2014
Having outperformed the S&P 500 in 2013 according to Baird, dental “stands at/near multi-year highs,” which means investors should “take a strict stock-specific approach to dental stocks this year.”
2013 dental products: Gawking in the shop window
In its introductory blurb, the 2014 Dental Outlook positions HSIC and XRAY as the likely top performers for 2014 and offers 10 themes that will drive the dental industry as a whole this year.
We know you’re catching up on a lot on this Thursday morning, so we offer a broad overview of the 10 themes:
- HSIC/XRAY most compelling near-term (patience on SIRO, ALGN, PDCO)
- Expect 1H slowing, 2H pick-up on North American dental consumables
- HSIC is predicted to outperform in 2014
- The stage is set for modest recovery in Europe
- Though CAD/CAM competition growing, near-term outlook is uncertain
- Dental implant market evolving (premiums can still grow)
- Clear aligners will continue to take share in ortho
- Potential ACA 2014 tailwinds, risks minimal
- HSIC remains the biggest benefactor of the corporate dental expansion
- Capital deployment strategies continue to evolve
The report also comes with a 2013 and five-year performance review of dental stocks, opportunities for 2014, company-specific checks, and an overall 2014 outlook. You can read the in-depth analysis in the PDF: Medical Technology: 2014 Dental Outlook – HSIC/XRAY Remain Top Ideas.
